Peroxisome Biogenesis Disorder Complementation Group 5 C3553941
An inherited condition where peroxisomes don't develop properly, affecting how cells process certain fats. This can lead to developmental delays, neurological problems, and organ involvement. Care involves managing symptoms.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Retinal degeneration causing vision impairment
Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Severe developmental delay
(neurologic)Craniofacial dysmorphism
(head_and_neck)Hepatomegaly with liver dysfunction
(hepatobiliary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Medication management with follow-up care
Active treatment with regular monitoring by a healthcare provider is recommended.
VLCFA-restricted diet
Strict dietary restriction of foods high in very long chain fatty acids forms the cornerstone of management for complementation group 5 peroxisome disorders. This includes avoiding certain oils, processed foods, and specific animal products.
Seizure control with metabolic-safe anticonvulsants
Anticonvulsant medications chosen for their safety profile in patients with metabolic disorders help manage seizure activity. Selection considers minimal hepatic metabolism and drug interactions.
Additional treatment options
Growth and nutritional status monitoring
Regular anthropometric measurements and nutritional assessments ensure adequate calorie and nutrient intake despite dietary restrictions. Growth failure requires nutritional intervention.
monitoringRespiratory support care
Patients with advanced peroxisome biogenesis disorders may require respiratory support including cough assist devices and airway clearance techniques. This prevents complications from impaired respiratory function.
lifestyleMultidisciplinary palliative care support
Palliative care integration provides comprehensive support addressing physical symptoms, emotional needs, and family quality of life in severe peroxisome biogenesis disorders. This approach complements disease-directed care.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Peroxisome Biogenesis Disorder Complementation Group 5 C3553941?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Steinberg SJ, Raymond GV, Braverman NE, Moser AB. Peroxisome biogenesis disorders: clinical guidelines for diagnosis and management. Mol Genet Metab. 2012;106(2):117-124.
Waterham HR, Ebberink MS. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta. 2012;1822(9):1430-1441.
Zhang R, Chen L, Jiralerspong S, et al. Clinical presentation and longitudinal outcomes in patients with Zellweger spectrum disorder. Orphanet J Rare Dis. 2020;15(1):215.
Fujiki Y, Okumoto K, Mukai S, et al. Peroxisome biogenesis disorders: novel therapeutic approaches. J Inherit Metab Dis. 2021;44(3):570-578.
Medication Comparisons
Compare medications used to treat Peroxisome Biogenesis Disorder Complementation Group 5 C3553941. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy